Home › Pulmonary Hypertension › NCT07224906

Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization

Observational Study of the HemoCept Device During Right Heart Catheterization at Boulder Heart

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
* Subjects can be any gender but must be age 18 or older.
* Subject is able and willing to provide informed consent and HIPAA authorization.
* Subject is able and willing to meet all study requirements.
* Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)

Exclusion Criteria:

* Subject is pregnant, breastfeeding, or intends to become pregnant during this study.

About the study

The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.

Sponsor: HemoCept Inc. · Participants: 50 · Started: Dec 1, 2025

Contact the study team

• Katharine Adkins · Phone: 303-442-2395

Official record on ClinicalTrials.gov — NCT07224906

Locations in the U.S.

Conditions

• Pulmonary Hypertension
• Heart Failure
• Heart Valve Diseases

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.